Loading...
Keywords
Last Name
Institution

Matthew McLaughlin

Concepts (81)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Cerebral Palsy
4
2020
11
3.200
Why?
Baclofen
4
2020
8
2.570
Why?
Pharmacogenetics
3
2019
115
1.540
Why?
Dose-Response Relationship, Drug
3
2020
109
1.170
Why?
Muscle Relaxants, Central
2
2020
6
1.080
Why?
Pandemics
2
2020
39
1.030
Why?
Neuromuscular Agents
1
2020
1
0.870
Why?
Rehabilitation
1
2020
1
0.870
Why?
Botulinum Toxins, Type A
1
2020
1
0.870
Why?
Research Support as Topic
1
2020
6
0.870
Why?
Drug Discovery
1
2020
5
0.870
Why?
Accreditation
1
2019
2
0.850
Why?
Electrodiagnosis
1
2019
4
0.850
Why?
Referral and Consultation
1
2019
33
0.820
Why?
Pediatrics
2
2020
219
0.820
Why?
Drug Delivery Systems
1
2019
5
0.810
Why?
Practice Patterns, Physicians'
1
2020
91
0.810
Why?
Humans
12
2021
5862
0.790
Why?
Precision Medicine
1
2019
39
0.780
Why?
Child
7
2021
2575
0.730
Why?
Arteriovenous Malformations
1
2015
1
0.620
Why?
Cervical Vertebrae
1
2015
4
0.620
Why?
Spinal Cord
1
2015
4
0.620
Why?
Thoracic Vertebrae
1
2015
4
0.620
Why?
Physical Therapy Modalities
1
2014
4
0.590
Why?
Probability
1
2014
21
0.580
Why?
Models, Statistical
1
2014
29
0.580
Why?
Administration, Oral
2
2020
83
0.400
Why?
United States
3
2021
678
0.400
Why?
Retrospective Studies
3
2021
1014
0.370
Why?
Genetic Variation
2
2019
151
0.340
Why?
Female
4
2020
3373
0.320
Why?
Young Adult
3
2021
551
0.280
Why?
Child, Preschool
2
2020
1476
0.280
Why?
Infant
2
2020
1351
0.260
Why?
Adolescent
2
2020
1900
0.260
Why?
Male
3
2020
3283
0.250
Why?
Brain Injuries
1
2021
11
0.240
Why?
Disability Evaluation
1
2020
7
0.220
Why?
Atmospheric Pressure
1
2020
1
0.220
Why?
Personal Protective Equipment
1
2020
1
0.220
Why?
Hydroxychloroquine
1
2020
1
0.220
Why?
Infectious Disease Transmission, Patient-to-Professional
1
2020
1
0.220
Why?
Adenosine Monophosphate
1
2020
2
0.220
Why?
Alanine
1
2020
2
0.220
Why?
Public-Private Sector Partnerships
1
2020
2
0.220
Why?
Metabolome
1
2020
4
0.220
Why?
Vulnerable Populations
1
2020
7
0.220
Why?
Off-Label Use
1
2020
5
0.220
Why?
Antimalarials
1
2020
4
0.220
Why?
Injections, Intramuscular
1
2020
6
0.220
Why?
Tandem Mass Spectrometry
1
2020
24
0.220
Why?
Muscles
1
2019
3
0.210
Why?
Drug Administration Schedule
1
2020
50
0.210
Why?
Body Weight
1
2020
65
0.210
Why?
Case-Control Studies
1
2020
111
0.210
Why?
Antiviral Agents
1
2020
28
0.210
Why?
Patient Selection
1
2020
61
0.210
Why?
Missouri
1
2019
86
0.210
Why?
Cross-Sectional Studies
1
2020
252
0.200
Why?
Molecular Targeted Therapy
1
2019
11
0.200
Why?
Research Design
1
2019
71
0.190
Why?
Age Factors
1
2019
234
0.190
Why?
Sulfonylurea Receptors
1
2017
3
0.190
Why?
Pharmacological Phenomena
1
2017
1
0.180
Why?
Pharmacokinetics
1
2017
19
0.180
Why?
Prognosis
1
2017
183
0.170
Why?
Polymorphism, Single Nucleotide
1
2017
206
0.170
Why?
Quadriplegia
1
2015
2
0.150
Why?
Magnetic Resonance Imaging
1
2015
74
0.150
Why?
Rehabilitation Centers
1
2021
3
0.060
Why?
Recovery of Function
1
2021
13
0.060
Why?
Cognition
1
2021
28
0.060
Why?
Inpatients
1
2021
41
0.060
Why?
Calibration
1
2020
6
0.050
Why?
Stereoisomerism
1
2020
9
0.050
Why?
Chromatography, Liquid
1
2020
11
0.050
Why?
Length of Stay
1
2021
212
0.050
Why?
Drug Monitoring
1
2020
22
0.050
Why?
Prospective Studies
1
2021
455
0.050
Why?
Drug-Related Side Effects and Adverse Reactions
1
2017
23
0.040
Why?
McLaughlin's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_